Category COVID-19 resources

Coronavirus: Dexamethasone proves first life-saving drug

A cheap and widely available drug can help save the lives of patients seriously ill with coronavirus

https://www.bbc.com/news/health-53061281

A cheap and widely available drug can help save the lives of patients seriously ill with coronavirus https://www.bbc.com/news/health-53061281

Why Does Science Come Last? – Perspectives on COVID-19

History shows us that there is no alternative to research in the battle against pandemics

https://www.outlookindia.com/magazine/story/india-news-why-does-science-come-last/303337

History shows us that there is no alternative to research in the battle against pandemics https://www.outlookindia.com/magazine/story/india-news-why-does-science-come-last/303337

Resource about ongoing COVID-19 trials worldwide and in India

Consolidated resource about ongoing COVID-19

https://clinicaltrials.gov/ct2/results/map/click?map.x=636&map.y=492&cond=COVID-19&map=SS&mapw=1259

Consolidated resource about ongoing COVID-19 https://clinicaltrials.gov/ct2/results/map/click?map.x=636&map.y=492&cond=COVID-19&map=SS&mapw=1259

Mutations in the Coronavirus Spike Protein

Antibodies against the Spike protein could range from neutralizing ones that will stop the virus in its tracks all the way to others that would cause antibody-dependent enhancement and make the viral infection even worse (see below), and we don’t know how the mutational landscape might alter the activity of any given monoclonal candidate. A new preprint on spike muations (from researchers at Los Alamos, Duke, and Sheffield) has gotten a great deal of attention in the last couple of days, and I think that a detailed look at it would be useful to help explain these issues.

https://blogs.sciencemag.org/pipeline/archives/2020/05/07/mutations-in-the-coronavirus-spike-protein

https://www.biorxiv.org/content/10.1101/2020.04.29.069054v1.full.pdf

Antibodies against the Spike protein could range from neutralizing ones that will stop the virus in its tracks all the way to others that would cause antibody-dependent enhancement and make the viral infection even worse (see below), and we don’t… Continue Reading →

Reducing transmission of novel coronavirus (SARS-CoV-2) – Masks and Aerosols

Masks and testing are necessary to combat asymptomatic spread in aerosols and droplets

https://science.sciencemag.org/content/early/2020/05/27/science.abc6197

Masks and testing are necessary to combat asymptomatic spread in aerosols and droplets https://science.sciencemag.org/content/early/2020/05/27/science.abc6197

Infographic on contact tracing

An infographic on how well designed digital contact tracing apps can help us fight COVID-19!

https://ncase.me/contact-tracing/

An infographic on how well designed digital contact tracing apps can help us fight COVID-19! https://ncase.me/contact-tracing/

Worldwide updates of COVID-19 infections

https://www.worldometers.info/coronavirus/

https://ourworldindata.org/covid-cases

What do new mutations in the novel coronavirus (SARS-CoV-2) mean?

To say that you’ve revealed the emergence of a more transmissible form of SARS-CoV-2 without ever actually testing it isn’t the type of thing that makes me feel comfortable as a scientist.” She and other virologists I’ve spoken with who were not involved in the Los Alamos research agree that the paper’s claims are plausible, but not justified by the evidence it presents. More important, they’re not convinced different strains of the coronavirus exist at all.

The origins of SARS-CoV-2

The first cases of COVID-19, the disease caused by the SARS-CoV-2 virus, were reported in December, 2019 in the city of Wuhan, in the Hubei province of China. It is therefore reasonable to assume that the disease originated in or around Wuhan.
41 cases of COVID-19 were reported to local health authorities in Wuhan, during December 16, 2019 to January, 2020. The clinical features of these patients were reported in this study in the journal Lancet, in February, 2020:

Useful COVID-19 resources and Database

Open-access and computational resources

https://datascience.nih.gov/covid-19-open-access-resources

Open-access and computational resources https://datascience.nih.gov/covid-19-open-access-resources

« Older posts

© 2020 — Powered by WordPress

ISRC Up ↑